A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia
• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients.
Gespeichert in:
| Autor*in: |
Hecht, Anna [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: N - Li, Danyang ELSEVIER, 2019, clinical and laboratory studies, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:39 ; year:2015 ; number:11 ; pages:1172-1177 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.leukres.2015.08.010 |
|---|
| Katalog-ID: |
ELV023261897 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV023261897 | ||
| 003 | DE-627 | ||
| 005 | 20230623170002.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.leukres.2015.08.010 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015003000011.pica |
| 035 | |a (DE-627)ELV023261897 | ||
| 035 | |a (ELSEVIER)S0145-2126(15)30363-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
| 084 | |a 43.12 |2 bkl | ||
| 084 | |a 43.13 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Hecht, Anna |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| 264 | 1 | |c 2015 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. | ||
| 650 | 7 | |a Relapse |2 Elsevier | |
| 650 | 7 | |a Acute promyelocytic leukemia |2 Elsevier | |
| 650 | 7 | |a Prognosis |2 Elsevier | |
| 650 | 7 | |a Molecular risk factors |2 Elsevier | |
| 650 | 7 | |a Survival |2 Elsevier | |
| 700 | 1 | |a Nowak, Daniel |4 oth | |
| 700 | 1 | |a Nowak, Verena |4 oth | |
| 700 | 1 | |a Hanfstein, Benjamin |4 oth | |
| 700 | 1 | |a Büchner, Thomas |4 oth | |
| 700 | 1 | |a Spiekermann, Karsten |4 oth | |
| 700 | 1 | |a Weiß, Christel |4 oth | |
| 700 | 1 | |a Hofmann, Wolf-Karsten |4 oth | |
| 700 | 1 | |a Lengfelder, Eva |4 oth | |
| 700 | 1 | |a Nolte, Florian |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Li, Danyang ELSEVIER |t N |d 2019 |d clinical and laboratory studies |g Amsterdam [u.a.] |w (DE-627)ELV002185202 |
| 773 | 1 | 8 | |g volume:39 |g year:2015 |g number:11 |g pages:1172-1177 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.leukres.2015.08.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 39 |j 2015 |e 11 |h 1172-1177 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a h ah |
|---|---|
| matchkey_str |
hechtannanowakdanielnowakverenahanfstein:2015----:mlclrikcritgaigalegnw1xrsineesorssrtfcto |
| hierarchy_sort_str |
2015 |
| bklnumber |
43.12 43.13 44.13 |
| publishDate |
2015 |
| allfields |
10.1016/j.leukres.2015.08.010 doi GBVA2015003000011.pica (DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hecht, Anna verfasserin aut A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier Nowak, Daniel oth Nowak, Verena oth Hanfstein, Benjamin oth Büchner, Thomas oth Spiekermann, Karsten oth Weiß, Christel oth Hofmann, Wolf-Karsten oth Lengfelder, Eva oth Nolte, Florian oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:11 pages:1172-1177 extent:6 https://doi.org/10.1016/j.leukres.2015.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 11 1172-1177 6 045F 610 |
| spelling |
10.1016/j.leukres.2015.08.010 doi GBVA2015003000011.pica (DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hecht, Anna verfasserin aut A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier Nowak, Daniel oth Nowak, Verena oth Hanfstein, Benjamin oth Büchner, Thomas oth Spiekermann, Karsten oth Weiß, Christel oth Hofmann, Wolf-Karsten oth Lengfelder, Eva oth Nolte, Florian oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:11 pages:1172-1177 extent:6 https://doi.org/10.1016/j.leukres.2015.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 11 1172-1177 6 045F 610 |
| allfields_unstemmed |
10.1016/j.leukres.2015.08.010 doi GBVA2015003000011.pica (DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hecht, Anna verfasserin aut A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier Nowak, Daniel oth Nowak, Verena oth Hanfstein, Benjamin oth Büchner, Thomas oth Spiekermann, Karsten oth Weiß, Christel oth Hofmann, Wolf-Karsten oth Lengfelder, Eva oth Nolte, Florian oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:11 pages:1172-1177 extent:6 https://doi.org/10.1016/j.leukres.2015.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 11 1172-1177 6 045F 610 |
| allfieldsGer |
10.1016/j.leukres.2015.08.010 doi GBVA2015003000011.pica (DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hecht, Anna verfasserin aut A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier Nowak, Daniel oth Nowak, Verena oth Hanfstein, Benjamin oth Büchner, Thomas oth Spiekermann, Karsten oth Weiß, Christel oth Hofmann, Wolf-Karsten oth Lengfelder, Eva oth Nolte, Florian oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:11 pages:1172-1177 extent:6 https://doi.org/10.1016/j.leukres.2015.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 11 1172-1177 6 045F 610 |
| allfieldsSound |
10.1016/j.leukres.2015.08.010 doi GBVA2015003000011.pica (DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hecht, Anna verfasserin aut A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia 2015 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier Nowak, Daniel oth Nowak, Verena oth Hanfstein, Benjamin oth Büchner, Thomas oth Spiekermann, Karsten oth Weiß, Christel oth Hofmann, Wolf-Karsten oth Lengfelder, Eva oth Nolte, Florian oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:11 pages:1172-1177 extent:6 https://doi.org/10.1016/j.leukres.2015.08.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 11 1172-1177 6 045F 610 |
| language |
English |
| source |
Enthalten in N Amsterdam [u.a.] volume:39 year:2015 number:11 pages:1172-1177 extent:6 |
| sourceStr |
Enthalten in N Amsterdam [u.a.] volume:39 year:2015 number:11 pages:1172-1177 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
Relapse Acute promyelocytic leukemia Prognosis Molecular risk factors Survival |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
N |
| authorswithroles_txt_mv |
Hecht, Anna @@aut@@ Nowak, Daniel @@oth@@ Nowak, Verena @@oth@@ Hanfstein, Benjamin @@oth@@ Büchner, Thomas @@oth@@ Spiekermann, Karsten @@oth@@ Weiß, Christel @@oth@@ Hofmann, Wolf-Karsten @@oth@@ Lengfelder, Eva @@oth@@ Nolte, Florian @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002185202 |
| dewey-sort |
3610 |
| id |
ELV023261897 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023261897</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623170002.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.08.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023261897</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30363-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hecht, Anna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relapse</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acute promyelocytic leukemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prognosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Molecular risk factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Verena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hanfstein, Benjamin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büchner, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spiekermann, Karsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiß, Christel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hofmann, Wolf-Karsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lengfelder, Eva</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolte, Florian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1172-1177</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.08.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">11</subfield><subfield code="h">1172-1177</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Hecht, Anna |
| spellingShingle |
Hecht, Anna ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| authorStr |
Hecht, Anna |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002185202 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival Elsevier |
| topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival |
| topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival |
| topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Relapse Elsevier Acute promyelocytic leukemia Elsevier Prognosis Elsevier Molecular risk factors Elsevier Survival |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d n dn v n vn b h bh t b tb k s ks c w cw w k h wkh e l el f n fn |
| hierarchy_parent_title |
N |
| hierarchy_parent_id |
ELV002185202 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
N |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002185202 |
| title |
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| ctrlnum |
(DE-627)ELV023261897 (ELSEVIER)S0145-2126(15)30363-5 |
| title_full |
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| author_sort |
Hecht, Anna |
| journal |
N |
| journalStr |
N |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
1172 |
| author_browse |
Hecht, Anna |
| container_volume |
39 |
| physical |
6 |
| class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Hecht, Anna |
| doi_str_mv |
10.1016/j.leukres.2015.08.010 |
| dewey-full |
610 333.7 |
| title_sort |
a molecular risk score integrating baalc, erg and wt1 expression levels for risk stratification in acute promyelocytic leukemia |
| title_auth |
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| abstract |
• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. |
| abstractGer |
• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. |
| abstract_unstemmed |
• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
| container_issue |
11 |
| title_short |
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia |
| url |
https://doi.org/10.1016/j.leukres.2015.08.010 |
| remote_bool |
true |
| author2 |
Nowak, Daniel Nowak, Verena Hanfstein, Benjamin Büchner, Thomas Spiekermann, Karsten Weiß, Christel Hofmann, Wolf-Karsten Lengfelder, Eva Nolte, Florian |
| author2Str |
Nowak, Daniel Nowak, Verena Hanfstein, Benjamin Büchner, Thomas Spiekermann, Karsten Weiß, Christel Hofmann, Wolf-Karsten Lengfelder, Eva Nolte, Florian |
| ppnlink |
ELV002185202 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.leukres.2015.08.010 |
| up_date |
2024-07-06T18:25:59.288Z |
| _version_ |
1803855183781822464 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV023261897</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623170002.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.08.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV023261897</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30363-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hecht, Anna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• A molecular risk score integrating BAALC, ERG and WT1 expression showed to be a strong prognostic marker for risk stratification in APL. • Especially the concurrent presence of molecular risk factors is associated with inferior outcome of APL patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relapse</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acute promyelocytic leukemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prognosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Molecular risk factors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nowak, Verena</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hanfstein, Benjamin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Büchner, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spiekermann, Karsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiß, Christel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hofmann, Wolf-Karsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lengfelder, Eva</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nolte, Florian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:1172-1177</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.08.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">11</subfield><subfield code="h">1172-1177</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4026117 |